SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -96.2% | 1 | -96.7% | 0.00% | -100.0% |
| Q2 2023 | $629 | -100.0% | 30 | -94.8% | 0.00% | -97.5% |
| Q1 2022 | $2,903,000 | +9264.5% | 576 | +453.8% | 0.08% | +636.4% |
| Q2 2021 | $31,000 | -99.0% | 104 | -14.0% | 0.01% | -83.1% |
| Q1 2021 | $3,172,000 | – | 121 | +656.2% | 0.06% | – |
| Q3 2019 | $0 | – | 16 | +33.3% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 12 | -99.0% | 0.00% | -100.0% |
| Q1 2019 | $44,000 | +2100.0% | 1,221 | +2497.9% | 0.04% | +1700.0% |
| Q3 2018 | $2,000 | -33.3% | 47 | -19.0% | 0.00% | -33.3% |
| Q2 2018 | $3,000 | +200.0% | 58 | +107.1% | 0.00% | +200.0% |
| Q1 2018 | $1,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |